Meghmani Organics Approves FY26 Financial Results, Including Standalone & Consolidated Figures
Meghmani Organics Limited reported audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Standalone profit after tax was ₹1,963.60 lakhs for the quarter and ₹12,526.34 lakhs for the year. Consolidated profit after tax was ₹803.12 lakhs for the quarter and ₹2,873.95 lakhs for the year. The board also approved the amalgamation of its wholly-owned subsidiaries.
The announcement includes the release of financial results, which are material to investors. The proposed amalgamation is a significant corporate action that could impact the company's structure and operations.
The company has announced its financial results, which show positive year-on-year growth in key financial metrics. The approval of the amalgamation also indicates a strategic move towards simplification and efficiency.
Meghmani Organics Limited's Board of Directors convened on May 14, 2026, to approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The results were reviewed by the Audit Committee prior to the board's approval and were accompanied by unmodified audit reports from statutory auditors M/s. Mukesh M. Shah & Co. The financial statements, detailing revenues, expenses, and profits for both segments (Pigments and Agro-chemicals) and consolidated group performance, are now available on the company's website.
The company reported total income of ₹49,039.64 lakhs for the standalone quarter ended March 31, 2026, with a profit after tax of ₹1,963.60 lakhs. For the full year ended March 31, 2026, standalone total income stood at ₹218,535.70 lakhs, and profit after tax was ₹12,526.34 lakhs.
Consolidated figures for the quarter ended March 31, 2026, showed total income of ₹51,158.08 lakhs and a net profit of ₹803.12 lakhs. For the full year, consolidated total income was ₹227,037.20 lakhs, with a net profit of ₹2,873.95 lakhs.
Additionally, the board had previously approved a Scheme of Amalgamation on April 4, 2026, for the merger of its wholly-owned subsidiaries, Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited, with Meghmani Organics Limited. This amalgamation is intended to streamline the group structure and achieve operational synergies, subject to regulatory approvals. The appointed date for the amalgamation is January 1, 2026. The company also made investments in Prozeal Green Power Private Limited, acquiring a 26% equity stake and investing in Compulsorily Convertible Debentures.
What to do with a filing like this
Meghmani Organics Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Meghmani Organics Limited. Read the original for the full detail.